TUCATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 57 adverse event reports in the FDA FAERS database where TUCATINIB was used for Neoplasm malignant.
Most Reported Side Effects for TUCATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,587 | 26.3% | 73 | 406 |
| Nausea | 862 | 14.3% | 29 | 273 |
| Fatigue | 843 | 14.0% | 49 | 216 |
| Vomiting | 483 | 8.0% | 24 | 204 |
| Death | 400 | 6.6% | 399 | 88 |
| Off label use | 392 | 6.5% | 31 | 112 |
| Malignant neoplasm progression | 361 | 6.0% | 37 | 26 |
| Palmar-plantar erythrodysaesthesia syndrome | 355 | 5.9% | 16 | 49 |
| Product dose omission issue | 332 | 5.5% | 19 | 122 |
| Asthenia | 322 | 5.3% | 34 | 134 |
| Decreased appetite | 286 | 4.7% | 16 | 67 |
| Metastases to central nervous system | 270 | 4.5% | 26 | 61 |
| Disease progression | 268 | 4.4% | 40 | 62 |
| Dehydration | 239 | 4.0% | 9 | 154 |
| Neoplasm progression | 237 | 3.9% | 35 | 37 |
Other Indications for TUCATINIB
Breast cancer female (1,890)
Her2 positive breast cancer (993)
Product used for unknown indication (825)
Breast cancer metastatic (738)
Breast cancer (552)
Metastases to central nervous system (77)
Colorectal cancer metastatic (52)
Colon cancer (49)
Invasive breast carcinoma (38)
Invasive ductal breast carcinoma (38)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)